4116
明基醫
-0.30 (-0.75%)39.606成交張數15.00本益比1.60股價淨值比5.05%殖利率2026-09-11資料日期
毛利率、營業利益率、淨利率
單季;近十年
單季營收
億元
| 季度 | 營收(億) | 營收年增 | 毛利(億) | 毛利率 | 營業利益(億) | 營業利益率 | 淨利率 |
|---|---|---|---|---|---|---|---|
| 2026Q2 | 14.3 | 7.1% | 4.6 | 32.3% | 0.9 | 6.3% | 4.1% |
| 2026Q1 | 13.2 | 7.9% | 4.3 | 32.3% | 0.7 | 5.2% | 0.9% |
| 2025Q4 | 13.7 | 4.2% | 4.5 | 32.9% | 1.0 | 7.3% | 1.4% |
| 2025Q3 | 13.2 | 8.3% | 4.3 | 32.5% | 0.8 | 6.2% | 2.1% |
| 2025Q2 | 13.3 | 13.5% | 4.1 | 31.0% | 0.9 | 6.6% | 0.7% |
| 2025Q1 | 12.3 | 16.2% | 4.0 | 32.3% | 0.7 | 5.9% | 1.8% |
| 2024Q4 | 13.2 | 9.1% | 4.1 | 30.8% | 1.0 | 7.9% | 2.0% |
| 2024Q3 | 12.1 | 5.2% | 3.7 | 30.5% | 0.9 | 7.0% | 2.2% |
| 2024Q2 | 11.8 | 60.0% | 3.6 | 30.5% | 0.8 | 7.1% | 2.5% |
| 2024Q1 | 10.6 | 54.0% | 3.1 | 29.6% | 0.6 | 5.7% | 2.1% |
| 2023Q4 | 12.1 | 55.2% | 3.7 | 30.9% | 1.2 | 10.0% | 3.1% |
| 2023Q3 | 11.5 | 52.7% | 3.5 | 30.3% | 1.0 | 8.8% | 3.2% |
| 2023Q2 | 7.4 | -8.3% | 2.2 | 29.8% | 0.4 | 5.9% | 2.4% |
| 2023Q1 | 6.9 | 11.6% | 2.1 | 31.3% | 0.4 | 6.3% | 3.3% |
| 2022Q4 | 7.8 | 85.9% | 2.4 | 31.1% | 0.5 | 5.9% | 3.0% |
| 2022Q3 | 7.6 | 100.6% | 2.2 | 29.3% | 0.5 | 6.9% | 4.6% |
| 2022Q2 | 8.0 | 137.7% | 2.2 | 27.4% | 0.6 | 7.8% | 4.3% |
| 2022Q1 | 6.2 | 85.5% | 1.8 | 28.8% | 0.2 | 3.2% | 14.2% |
| 2021Q4 | 4.2 | 2.4% | 1.6 | 38.0% | 0.2 | 5.6% | 2.9% |
| 2021Q3 | 3.8 | 2.6% | 1.3 | 34.3% | 0.1 | 3.4% | 2.2% |
| 2021Q2 | 3.4 | 4.2% | 1.0 | 30.5% | 0.0 | 0.8% | 1.0% |
| 2021Q1 | 3.3 | 10.3% | 1.2 | 36.3% | 0.1 | 2.3% | 1.5% |
| 2020Q4 | 4.1 | 14.6% | 1.7 | 42.1% | 0.5 | 11.5% | 7.7% |
| 2020Q3 | 3.7 | 5.1% | 1.5 | 40.9% | 0.3 | 8.2% | 3.9% |
| 2020Q2 | 3.2 | -5.0% | 1.1 | 35.2% | 0.1 | 2.7% | 2.6% |
| 2020Q1 | 3.0 | -9.8% | 1.2 | 38.4% | 0.1 | 3.8% | 2.6% |
| 2019Q4 | 3.6 | 2.8% | 1.4 | 40.3% | 0.4 | 10.0% | 6.6% |
| 2019Q3 | 3.5 | 12.8% | 1.5 | 41.9% | 0.3 | 9.6% | 5.6% |
| 2019Q2 | 3.4 | 7.7% | 1.3 | 38.1% | 0.2 | 6.0% | 3.5% |
| 2019Q1 | 3.3 | 28.1% | 1.3 | 38.2% | 0.3 | 7.9% | 6.1% |
| 2018Q4 | 3.5 | 29.8% | 1.4 | 40.5% | 0.4 | 11.1% | 8.2% |
| 2018Q3 | 3.1 | 3.2% | 1.2 | 38.3% | 0.2 | 8.0% | 5.4% |
| 2018Q2 | 3.2 | 23.1% | 1.1 | 35.2% | 0.2 | 6.4% | 5.2% |
| 2018Q1 | 2.6 | 22.4% | 1.0 | 36.6% | 0.1 | 3.9% | 2.0% |
| 2017Q4 | 2.7 | 24.4% | 1.1 | 39.4% | 0.2 | 9.0% | 6.4% |
| 2017Q3 | 3.0 | 38.5% | 1.1 | 36.9% | 0.2 | 5.9% | 3.6% |
| 2017Q2 | 2.6 | 13.2% | 0.9 | 35.9% | 0.2 | 7.0% | 4.9% |
| 2017Q1 | 2.1 | -2.1% | 0.7 | 34.6% | 0.1 | 4.5% | 2.9% |
| 2016Q4 | 2.1 | – | 0.8 | 36.8% | 0.2 | 8.0% | 6.8% |
| 2016Q3 | 2.2 | – | 0.7 | 33.5% | 0.1 | 5.4% | 4.0% |